This case deepens our understanding of ALK+ NSCLC with diverse genomic alterations and provides insight into the new treatment of EML4-ALK+ lung adenocarcinoma with multiple gene fusions. The gene discussed is EML4; the disease is non-small cell lung carcinoma.